Grafix: payments to doctors
Payments that named Grafix as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $5.4M
- Providers
- 8,615
- Transactions
- 25,650
- Average per transaction
- $212
The per-transaction average — $212 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 8,615 providers the average total is $632, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Smith+Nephew | $4,763,044 | 87.5% |
| Osiris Therapeutics Inc. | $673,827 | 12.4% |
| Linvatec Corporation | $8,983 | 0.2% |